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Abstract
Prion diseases are transmissible neurodegenerative conditions affecting human and a wide range of animal species.
The pathogenesis of prion diseases is associated with the accumulation of aggregates of misfolded conformers of
host-encoded cellular prion protein (PrP
C). Animal prion diseases include scrapie of sheep and goats, bovine
spongiform encephalopathy (BSE) or mad cow disease, transmissible mink encephalopathy, feline spongiform
encephalopathy, exotic ungulate spongiform encephalopathy, chronic wasting disease of cervids and spongiform
encephalopathy of primates. Although some cases of sporadic atypical scrapie and BSE have also been reported,
animal prion diseases have basically occurred via the acquisition of infection from contaminated feed or via the
exposure to contaminated environment. Scrapie and chronic wasting disease are naturally sustaining epidemics.
The transmission of BSE to human has caused more than 200 cases of variant Cruetzfeldt-Jacob disease and has
raised serious public health concerns. The present review discusses the epidemiology, clinical neuropathology,
transmissibility and genetics of animal prion diseases.
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Background
Prion diseases are transmissible protein misfolding dis-
orders in which misfolding of a host-encoded prion pro-
tein (PrP) occurs. PrP may exist in two forms: a normal
cellular prion protein designated as PrP
C and a patho-
genic misfolded conformer designated as PrP
Sc.T h e
s u p e r s c r i p t( S c )h a sb e e nu s e dt or e f e rt os c r a p i e ,t h e
first and the most ancient animal transmissible spongi-
form encephalopathy (TSE). Many authors also use
superscripts other than (Sc) to distinguish normal and
pathogenic (disease-causing) isoforms. These include
( r e s )f o rr e s i s t a n ta n d( D i s )f or disease. An abbreviated
name of a prion disease can also be used as superscript
to point out the origin of the pathogenic isoform i.e.
PrP
Sc or PrP
CJD. The pathogenic conformers are simply
called prions (the infectious protein particles) [1].
According to seeding-nucleation model, the preexist-
ing or acquired PrP
Sc oligomers catalyze the conversion
of PrP
C molecules into PrP
Sc fibrils the breakage of
which provides more PrP
Sc templates for the conversion
process. The process of prions’ propagation in the brain
results in the pathogenesis of prion diseases [2]. Sixteen
different variants of prion disease have been reported so
far: 9 in humans and 7 in animals. The etiology, host
range and year of description for these disease variants
are given in Table 1. In the present review, a brief
description of animal prion diseases is provided.
Scrapie
Scrapie is the ancient form of TSEs. It is known since
1732 and has occurred in sheep, goats and moufflons
[3]. As is the case with other prion diseases, clinico-
pathological phenotypes of scrapie vary according to the
prion strain and animals’ genetic background. Multiple
p r i o ns t r a i n sm a ye x i s ti nas i n g l es c r a p i ei s o l a t ea n da
PrP
Sc conformer underrepresented in one breed may be
selected as dominantly propagating strain in another
breed [4,5]. Clinical symptoms may include behavioral
changes, blindness, ataxia, incoordination, hyperexitabil-
ity and tremors. Intense pruritus is the most common
symptom which usually leads to wool loss by rubbing
and scraping, and results in a characteristic nibbling
response from animal when the dorsum is scratched or
pressure over the base of tail is applied. The incubation
period of scrapie is 2-5 years and death occurs within 2
weeks to 6 months after clinical onset. Neuropathologi-
cal signs are spongiform vacuolation, astrogliosis and
the deposition of PrP
Sc amyloid plaques in the central
nervous system (CNS). PrP
Sc has been detected in the
nervous system, tonsils, spleen, lymph nodes, nicitating
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mal colon. Detection of PrP
Sc in the third eye lid is used
a sr a p i dd i a g n o s t i ct e s ti nl i v ea n i m a l s .E x c r e t i o n sa n d
secretions have also been found to contain PrP
Sc infec-
tivity which may transmit between animals horizontally.
About 3-5% animals per affected flock may die annually
and an increase up to 20% in annual mortality rates has
also been noted in some flocks [3,6-9].
The abovementioned facts are for classical or typical
sheep scrapie. Atypical cases of both sheep and goat
scrapie have also been described. In atypical scrapie, the
major clinical symptoms are ataxia and incoordination.
Pruritus is uncommon. Clinical signs of goat scrapie
overlap with those of sheep scrapie and may include
irritability, loss of inquisitiveness, unusual alertness, rest-
lessness, impaired vision, hyperesthesia, incoordination,
posture abnormalities, tremors, and teeth grinding, sali-
vation, or regurgitation of rumen contents [10-12].
Several amino acid polymorphisms in both the ovine
and caprine PrP encoding genes (PRNP) have been
reported to be associated with scrapie susceptibility. Sheep
exposed to natural or experimental PrP
Sc infection have
been shown to gain maximum scrapie resistance in the
presence of Q171R polymorphism and maximum scrapie
susceptibility in the presence of A136V polymorphism. A
three codon system based on A136V, R154H and Q171R/
H polymorphisms has been developed by using five alleles
(ARQ, VRQ, AHQ, ARR and ARH). These five alleles can
be combined into 15 genotypes i.e. ARR/ARR or VRQ/
ARQ which, in turn, can be classified into five groups (R1-
R5) according to the susceptibility they confer to the dis-
ease. The most resistant R1 genotype is ARR/ARR and the
most susceptible R5 genotypes are VRQ/VRQ, VRQ/ARQ,
VRQ/ARH and VRQ/AHQ. The remaining genotypes are
of intermediary susceptibility. This risk classification sys-
tem has helped many European states in selective breeding
of sheep against scrapie. The selective breeding of sheep
against scrapie caused no considerable negative impacts
on production, reproduction and health of animals
[13,14]. The presence of ARR/ARR in either ewe or her
fetus would resist the PrP
Sc accumulation in placenta
[7,11]. Though ovine PRNP polymorphism has been abun-
dantly linked to the scrapie risk, a few studies have been
carried out for the analysis of caprine PRNP gene in this
regard. This is due to the fact that the prevalence of typical
scrapie outbreaks in goat is comparatively much lower
than in sheep. However, caprine PrP polymorphisms
I142M, H143R, N146S/D, R154H, R211Q and Q222K
have been shown to be associated with low scrapie risk.
Atypical scrapie is also influenced by variations in PRNP
and has been reported to occur in animals carrying geno-
types conferring resistance to typical scrapie [10-12].
Transmissible Mink Encephalopathy (TME)
TME is a rare TSE of farmed mink. Mink is a small
semi-aquatic wild mammal that is raised in several
Table 1 Etiology of prion diseases
Animal prion diseases
Disease Host Etiology Year of Description
Scrapie Sheep, Goats Infection with Prions of unknown origin 1732
TME Mink Infection with Prions of either sheep or cattle origin 1947
CWD Cervids Infection with Prions of unknown origin 1967
BSE Cattle Infection with Prions of unknown origin 1986
EUE Nyala, Kudu Infection with Prions of BSE origin 1986
FSE Cats Infection with prions of BSE origin 1990
NHP Lemurs Infection with Prions of BSE origin 1996
Human prion diseases
Disease Host Etiology Year of Description
Kuru Human Ritualistic Cannibalism or “Transumption” 1900s
sCJD Human Spontaneous PrP
C ®PrP
Sc conversion or somatic mutation 1920
fCJD Human Mutations in PRNP 1924
GSS Human Mutations in PRNP 1936
iCJD Human Infection with Prions of human origin by cadaveric corneal grafts, hGH or dura mater 1974
FFI Human PRNP haplotype 178N-129M 1986
vCJD Human Infection with Prions of BSE origin 1996
sFI Human Spontaneous PrP
C ®PrP
Sc conversion or somatic mutation 1999
VPSPr Human Spontaneous PrP
C ®PrP
Sc conversion or somatic mutation 2008
TME (transmissible mink encephalopathy), CWD (chronic wasting disease), BSE (bovine spongiform encephalopathy), EUE (exotic ungulate spongiform
encephalopathy), FSE (feline spongiform encephalopathy), NHP (TSE in non-human primates), sCJD (sporadic Cruetzfeldt-Jacob disease), fCJD (familial CJD), GSS
(Gerstmann-Sträussler-Scheinker syndrome), iCJD (iatrogenic CJD), FFI (fatal familial insomnia), vCJD (variant CJD), sFI (sporadic fatal insomnia), VPSPr (variably
protease-sensitive prionopathy)
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Page 2 of 8countries for the production of fur. TME was first
recognized in Wisconsin and Minnesota in 1947. Subse-
quently, TME outbreaks in US have occurred in 60s and
70s with the most recent outbreak in 1985. TME has
also been seen in farmed mink in Canada, Finland, East
Germany and the former USSR [15]. Although the ori-
gin of TME is still unknown, contaminated feed, mainly
with the scrapie agent, was presumed to be the main
source of infection. Mink inoculated with various strains
of the scrapie agent revealed the development of TME.
Oral infection of minks with the classical BSE agent also
caused TME, but animals exhibited docile rather than
aggressive behavior. More recently, the L-type BSE
agent has been described as the most likely candidate
for being causative of TME [16,17]. TME is readily
transmissible to raccoons by parenteral, intracerebral
and oral routes, and can intracerebrally be transmitted
to striped skunks, ferrets, American sable (pine mar-
tens), beech martens, cattle, sheep, goats, hamsters and
non-human primates such as rhesus macaque, stump-
tailed macaque and squirrel monkey. Non-transgenic
mice are not susceptible to TME [17]. TME passaged in
cattle has also been transmitted to mink both intracere-
brally and orally with incubation periods of only 4-7
months [18]. A bifurcation in clinical phenotypes with
distinct incubation periods, neuropathological lesions
and biochemical profiles was produced in hamsters on
inoculation with TME. Depending on clinical symptoms
of the disease, one strain was named as “hyper (HY)”
while the other as “drowsy (DY)” [19]. On coinfection of
these strains, DY shows a dominant competition for the
recruitment of cellular PrP
C into oligomers, and may
reduce the incubation time or even block the ability of
HY to cause the disease [20].
When housed in the same cage, minks may acquire
the infection through cannibalism or biting of each
other. However, at least in one outbreak, kits housed
with their dams did not develop the disease. Environ-
mental exposure and vertical transmission have not
been found to cause the spread of the infection. TME
has been detected only in adult mink, and may cause
60-90% or even 100% mortality during an outbreak
[http://www.cfsph.iastate.edu].
The clinical manifestation of the disease includes
behavioral changes such as increased aggressiveness and
hyperesthesia, depression, restlessness, and neglect in
parental care and coat grooming. The affected minks
often soil the nest or scatter feces in the cage. At the
earlier disease stages, they may also exhibit difficulty
eating and swallowing. Later, symptoms such as abnor-
mal gait, ataxia, incoordination, occasional tremors,
clenching of the jaw, curved tail like those of squirrels,
and compulsive biting or mutilation of objects or of the
self, particularly of the tail, may be noted. Near the end
of the disease course, convulsions may occur, and minks
become somnolent and unresponsive, and can be seen
to press their heads against the cage for hours. Incuba-
tion time in naturally occurring TME may range from 6
to 12 months, and death usually occurs within 2 to 8
weeks [17, http://www.cfsph.iastate.edu].
Neuropathological features of TME include extensive
spongiform degeneration in the neuropil of the brain.
Astrocytosis also occurs. Spongiform changes are
intense in the cerebral cortex, particularly in the frontal
cortex, as well as the corpus striatum, thalamus and
hypothalamus, but are less severe in the midbrain, pons
and medulla, and usually, are not evident in the cerebel-
lum and spinal cord. In addition to CNS, PrP deposits
of the TME agent, but not amyloid plaques, have been
detected in spleen, intestine, the mesenteric lymph
node, thymus, kidney, liver and salivary glands of experi-
mentally infected mink [17, http://www.cfsph.iastate.
edu].
Chronic Wasting Disease (CWD)
CWD is a TSE of captive as well as free-ranging mem-
bers of the family Cervidae. From 1967 to now, CWD
has been seen in 14 USA states, 2 Canadian provinces
and in imported animals in South Korea. However, sur-
veillance for CWD has been at minimum around the
globe. The affected species include mule deer, white-
tailed deer, black-tailed deer, Rocky Mountain elk, and
Shira’s moose. The origin of CWD is still unknown,
although intracerebral transmission of the scrapie agent
has been shown to induce the disease in elk. More than
1P r P
CWD strains may exist among the affected popula-
tions [17,21-23]. Epidemiological and experimental data
provide evidence that horizontal transmission of CWD
can efficiently occur by contact with affected animals or
through environmental exposure [17,22,24-26]. Until
now, the natural transmission of CWD has not been evi-
dent in humans who have been exposed for long to the
affected area and consumed venison, and also not in
domestic bovids such as sheep and cattle cosharing the
habitat with the affected cervids. Moreover, transgenic
mice expressing either the human, ovine or bovine PrP
C
coding frames did not develop the disease when inocu-
l a t e dw i t ht h eC W Da g e n t[ 1 7 , 2 2 , 2 6 ] .H o w e v e r ,o t h e r
cervids such as red deer and reindeer/caribou are also
susceptible to CWD through intracerebral and oral
routes and may be contributive to sustaining the
ongoing CWD epidemic in North America [27,28].
CWD is also intracerebrally transmissible to cattle,
sheep, goats, ferrets, hamsters, bank voles, mink, rac-
coons and squirrel monkeys [22].
The PrP
CWD infectivity can be detected in the nervous
system, the lymphoreticular system, the hematopoietic
system, skeletal and cardiac muscles, pancreas, fat,
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and/or experimentally infected animals [17,22,25,29,30].
Virtually, no tissue in infected cervids should be consid-
ered free of the CWD agent. Susceptible animals may
acquire the infectivity from their habitats during feeding
on grasses or by drinking water contaminated with
PrP
CWD which affected cervids excrete or secrete or
deposit into the environment, even in the asymptomatic
carrier state, in the form of feces, urine, saliva, blood,
placenta and carcasses [17,22,31-33]. Acquisition of the
infectivity may be enhanced further by oral abrasions
and nasal exposure to PrP
CWD-containing droplets and
aerosols [34,35]. An important point is that the TSE
agents can bind to soil particles, persist there for years
still retaining the infectivity and transmit the disease via
oral route with even more efficiency [36-38]. These data
provide a plausible explanation for the high incidence of
CWD and efficient transmission of the infectivity among
cervids.
Prevalence of the disease in affected herds may range
from 0.1 to 50% or even 100%, sometimes. CWD has
also been detected in USA in areas far from the original
endemic area and raised several questions: Whether the
infectivity has been transported to these areas illegally in
the form of tainted materials or infected animals or by
some another way, whether the scrapie agent has
adapted to cause CWD by repeated natural passages
into the deer, or if the PrP
C conversion in cervids is
proficient enough to result in the sporadic emergence of
the disease, which may in turn establish the epidemic by
horizontal transmission. Given that the routes of
PrP
CWD transmission are still uncertain, managerial
decisions for the disease eradication based on the super-
vision of animal trade, and quarantine or mandated
destruction of effected herds or flocks may appear less
promising. Therefore, therapeutic intervention targeting
molecular mechanisms involved in the pathogenesis of
the disease may be a better substitute for the control of
epidemics of CWD and scrapie [22]. In addition, PRNP
polymorphisms S96G, M132L and S225F in cervids have
been associated with resistance to CWD and may, at
least in the case of captive animals, be helpful in the dis-
ease management by selective breeding [22,30,39-41].
In free-ranging cervids, the increased prevalence of
CWD allied with the lower survival of diseased animals
is thought to provide predators like mountain lions an
opportunity for selective successful predation. Such a
selective predation would lead to local imbalances in
ecological dynamics of food webs and nutrients recy-
cling [42,43].
Chronic wasting of carcasses or weight loss, on the
basis of which the disease is called “chronic wasting dis-
ease”, is very common in affected cervids. CWD can
also cause these animals to have a rough, dry coat,
patchy retention of the winter coat in summer. In sub-
clinical or early clinical CWD, affected cervids particu-
larly elk, may also show some other highly subtle
symptoms including lassitude, sudden death in deer
after handling, a lowered head and drooping ears and
behavioral changes such as having fixed gaze and loss of
fear of humans. With the progression of the disease, fol-
lowing more perceptible symptoms may arise: flaccid
hypotonic facial muscles, ataxia, head tremors, teeth
grinding, repetitive walking close to the boundary of the
enclosure, hyperexcitability with handling, excessive sali-
vation due to difficulty swallowing, esophageal dilation
or ruminal atony, regurgitation of ruminal fluid, poly-
uria, polydipsia, syncope, and aspiration pneumonia.
Many animals become severely emaciated before they
die. Incubation periods in CWD lie within the range of
16 months to 5 years and the disease equally affects
both males and females. Death usually occurs within a
period of 1 year after the onset of clinical signs [17,
http://www.cfsph.iastate.edu].
On histopathological examination, CNS of the affected
cervids shows intraneuronal vacuolation, degeneration
and loss of neurons, extensive neuropil spongiosis,
astrocytic hypertrophy and hyperplasia, and occasional
amyloid plaques. Spongiform lesions are mainly
observed within the thalamus, hypothalamus, midbrain,
pons, medulla oblongata, the olfactory tubercle and cor-
tex. The most consistent histological lesions and
PrP
CWD immunohistochemical staining are seen within
the dorsal motor nucleus of the vagus nerve, which is
considered the first site of PrP
CWD accumulation.
Importantly, the clinical signs of polyuria and polydipsia
and the low urine specific gravity in clinically dehy-
drated animals may be attributed to severe lesions in
the supra-optic and paraventricular nuclei, where the
production of anti-diuretic hormone occurs [17].
Bovine Spongiform Encephalopathy (BSE or “Mad Cow”
disease)
Bovine Spongiform Encephalopathy (BSE) or “the Mad
Cow disease” is a progressive and invariably fatal neuro-
degeneration in cattle. The clinical signs of BSE may
include tremors, gait abnormalities particularly of hin-
dlimb (ataxia), aggressive behavior, apprehension, and
hyperreactivity to stimuli. PrP
Sc accumulation and spon-
giform vacuolation are usually found in the brain [7]. At
the terminal stages of the disease, BSE prions may also
be detected in spinal cord, retina, ileum, adrenal glands,
tonsils, bone marrow, peripheral nerves, dorsal root
ganglia, trigeminal ganglion and thoracic ganglia. The
BSE infectivity may be observed in brain tissues as early
as 2 years after post inoculation. Epidemiological and
transmission studies have found no evidence of BSE
prions in milk, semen or embryos and there is little or
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offspring of infected animals have shown an increased
risk for disease development. The incubation period for
BSE is 2 to 8 years and most of BSE cases have been
found in 4 to 5 years old dairy cattle [[7], http://www.
cfsph.iastate.edu]. Apart from BSE strain causing classi-
cal BSE, two other strains (H-type and L-type) causing
atypical BSE have been described. Most of atypical BSE
cases have been detected during active surveillance tar-
geting fallen stocks and slaughtered animals [44,45].
Amyloid plaques can be detected in animals with atypi-
cal L-form BSE, although they are not typical of classical
BSE [http://www.cfsph.iastate.edu].
BSE cases have occurred worldwide in nearly 0.2 mil-
lion Holstein-Freisian Bos taurus cattle, 1 Bos indicus
animal, and 1 Bos taurus × Bos indicus cow
[7,44,46-48]. BSE first appeared in mid 80s in UK, soon
evolved to epidemic proportions with 1000 cases occur-
ring per week in 1992, and has been shown to be natu-
rally transmissible to a number of zoo species [17]. BSE
has also transmitted to humans in the form of a variant
of Cruetzfeldt-Jacob disease (vCJD) [49]. The practice of
using meat and bone meal (MBM) possibly contami-
nated with infectious mammalian pathogenic prions in
cattle feed was considered the likely cause of the BSE
epidemic. A ban on the use of MBM in the ruminants
feed ultimately resulted in a progressive decline of the
epidemic [44]. Natural cases of transmissions of BSE
have been described in sheep and goats. Such bovid ani-
mals may be an additional source of BSE transmission
to humans [50,51]. Indeed, transgenic mice expressing
human PrP
C a r em o r es u s c e p t i b l et os h e e p - p a s s a g e d
B S Et h a nc l a s s i c a lB S E[ 5 2 ] .O r i g i n so fB S Ea r e
unknown. The accidental inclusion of tissues in MBM
from familial or sporadic BSE cases, sheep with scrapie
or CJD patients may be responsible [46,47,53-56].
Although several PRNP variants have been described
for cattle [57,58], only three amongst these variants, a
23 bp indel in the PRNP promoter, a 12 bp indel in the
first intron and an E211K polymorphism, are known to
confer susceptibility to BSE [46,47,58-60].
Exotic Ungulate Spongiform Encephalopathy (EUE)
E U Ei saT S Eo fe x o t i cz o or u m i n a n t so ft h ef a m i l y
Bovidae. During a period overlapping with BSE epi-
demic, 6 greater kudu, 6 elands, 2 each of Arabian oryx
and ankole cattle, and 1 each of gemsbok, nyala, scimi-
tar-horned oryx and bison were diagnosed with EUE
from UK. The affected animals had been fed meat and
bone meal (MBM) derived from ruminants. Indeed,
mice inoculated with brain homogenates from greater
kudu and nyala with EUE and from cattle with BSE
developed a TSE with similar profiles of neuropathologi-
cal lesions and incubation periods. Strain typing studies
in these mice also revealed a similarity between the EUE
and BSE strains, supporting the hypothesis that EUE is
caused by an infection with PrP
BSE. The course of EUE
and clinical symptoms varies, according to the species,
and are distinct from those of BSE and scrapie. All EUE
cases died of this disease [17,61,62].
Feline Spongiform Encephalopathy (FSE)
FSE is a TSE of domestic cats and captive wild members
of the family Felidae. Since 1990 to present, nearly 100
domestic cats usually from UK including 1 case each
from Northern Ireland, Norway, Liechtenstein and Swit-
zerland, and 29 captive wild cats including 15 cheetahs,
4 lions, 3 each of ocelots, pumas, tigers and an Asian
golden cat have been diagnosed with FSE. FSE cases in
wild cats have been seen in zoos of UK, France, Austra-
lia, Ireland, and Germany. All large zoo cats diagnosed
with FSE outside UK originated from UK except a
female cheetah and her cub born in France and another
thought to have acquired the infectivity in Netherland
where she was born. As most of the FSE cases occurred
in parallel to the BSE epidemic, exposure of affected
cats to feed contaminated with PrP
BSE was taken as cau-
sative of the disease. Mice inoculated with brain homo-
genates from cats with FSE and cattle with BSE
developed a TSE with similar profiles of neuropathologi-
cal lesions and incubation periods. Strain typing studies
in these mice also revealed a similarity between the FSE
and BSE strains, supporting the hypothesis that FSE is
caused by an infection with BSE prions [17,63,64]. How-
ever, in 1998, a domestic cat and his owner have been
shown to be affected with a similar strain distinct from
PrP
BSE. A bifurcation in phenotypes was noted: the man
revealed a phenotype reminiscent of sCJD rather than of
vCJD and the cat showed a clinical phenotype distinct
from FSE. It remains unknown whether this incidence
was due to a chance, whether a horizontal transmission
occurred between the man and the cat, or if both con-
tracted the disease from the same unknown source [65].
Another cat infected with such strain and the acquisi-
tion of FSE from the environment has not been reported
yet. With a ban on the use as pet feed of bovine spleen
and CNS tissue, the FSE epidemic declined rapidly. All
FSE cases have been seen in cats aged more than 2
years [17].
The clinical manifestation of the disease includes
severe behavioral changes, depression, restlessness and
n e g l e c ti nc o a tg r o o m i n g .T h eb e h a v i o r a lc h a n g e s
include fear, uncharacteristic aggressiveness or unusual
timidity and hiding. Abnormal or hypermetric gait and
ataxia, mainly of the hind limbs, are also characteristics
of FSE. Affected cats often show poor judgment of dis-
tance and hyperesthesia to touch or noise, and may also
develop tremors, stare vacantly or circle. In addition,
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pupils have been reported as symptoms of FSE. At the
end of the disease course, convulsions may occur and
somnolence is common. Death occurs after 3-8 and 8-
10 weeks of clinical onset of the disease in domestic
cats and cheetahs, respectively [[17], http://www.cfsph.
iastate.edu].
Neuropathological profiles of FSE include spongiform
degeneration in the neuropil of the brain and spinal
cord, with a predominance of the most severe lesions in
the medial geniculate nucleus of the thalamus and the
basal nuclei. PrP deposits of the FSE agent, with charac-
teristic florid plaques, have been detected by immuno-
histochemistry in the central and peripheral nervous
system, retina, lymphoreticular system, kidney and adre-
nal glands [[17,63,64], http://www.cfsph.iastate.edu).
TSE in non-human primates (NHP)
Two Mayotte brown lemurs and 1 each of white
fronted brown lemur, mongoose lemur and Rhesus
macaque from a zoo and three primate facilities in
France were diagnosed with a TSE, from 1996 to 1999.
Although a large number of non-human primates are
susceptible to experimental exposure to various TSE
strains, they have never been reported before this to
contract a TSE naturally. The affected animals had
been fed primate diets likely contaminated with meat
from UK. Indeed, lemurs experimentally inoculated
with brain homogenates from cattle with BSE devel-
oped a TSE with profiles of neuropathological lesions
similar to those seen in naturally infected lemurs.
Strain typing studies also revealed a similarity between
the two strains. Further, in these naturally and experi-
mentally infected lemurs, immunohistochemical exami-
nation showed similar staining patterns and the
distribution of PrP
res in the brain, spinal cord, tonsils,
spleen and various sections of the gut and gut-asso-
ciated lymphatic tissues [17,66].
Conclusion
Animal prion diseases other than scrapie and CWD
have been controlled by the withdrawal of source of
contamination from animals’ diet. However, scrapie and
CWD are self-sustaining epidemics and their control
necessitates the development of therapeutics that can
block the cellular spread of infectivity or the propaga-
tion of prions [22]. No case of prion disease has been
observed from Pakistan up till now. We have recently
performed the analysis of the bovine PRNP in 236 Pakis-
tani cattle representing 7 different breeds. The results
suggest that Pakistani cattle are genetically more resis-
tant to BSE as compared to European cattle (unpub-
lished data).
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